Related references
Note: Only part of the references are listed.Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family
Nathalie Brouwers et al.
ARCHIVES OF NEUROLOGY (2007)
GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease
Genta Ito et al.
BIOCHEMISTRY (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred
David Gosal et al.
MOVEMENT DISORDERS (2007)
The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence
E. K. Tan et al.
HUMAN GENETICS (2007)
Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease
Nathan Pankratz et al.
MOVEMENT DISORDERS (2006)
Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease
Nathalie Brouwers et al.
BRAIN (2006)
LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East:: Evidence of two distinct founding events beginning two millennia ago
Cyrus P. Zabetian et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
Marc Cruts et al.
NATURE (2006)
Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease
E. K. Tan et al.
MOVEMENT DISORDERS (2006)
A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan
Alessio Di Fonzo et al.
NEUROGENETICS (2006)
LRRK2 in Parkinson's disease: protein domains and functional insights
Ignacio F. Mata et al.
TRENDS IN NEUROSCIENCES (2006)
A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD
J van der Zee et al.
BRAIN (2006)
Genetics of Parkinson disease: paradigm shifts and future prospects
MJ Farrer
NATURE REVIEWS GENETICS (2006)
LRRK2 mutations in Spanish patients with Parkinson disease -: Frequency, clinical features, and incomplete penetrance
C Gaig et al.
ARCHIVES OF NEUROLOGY (2006)
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease
A Di Fonzo et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2006)
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
CJ Gloeckner et al.
HUMAN MOLECULAR GENETICS (2006)
Lrrk2 pathogenic substitutions in Parkinson's disease
IF Mata et al.
NEUROGENETICS (2005)
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease:: clinical, pathological, olfactory and functional imaging and genetic data
NL Khan et al.
BRAIN (2005)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor -: art. no. e65
S Goldwurm et al.
JOURNAL OF MEDICAL GENETICS (2005)
LRRK2 gene in Parkinson disease -: Mutation analysis and case control association study
C Paisán-Ruíz et al.
NEUROLOGY (2005)
A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations
CP Zabetian et al.
NEUROLOGY (2005)
LRRK2 haplotype analyses in European and North African families with Parkinson disease:: A common founder for the G2019S mutation dating from the 13th century
S Lesage et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
LRRK2 R1441G in Spanish patients with Parkinson's disease
IF Mata et al.
NEUROSCIENCE LETTERS (2005)
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism:: Evidence of a common founder across European populations
J Kachergus et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Familial Parkinson's disease:: Clinical and genetic analysis of four Basque families
C Paisàn-Ruìz et al.
ANNALS OF NEUROLOGY (2005)
Clinical and positron emission tomography of Parkinson's disease caused by LRRK2
DG Hernandez et al.
ANNALS OF NEUROLOGY (2005)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
EM Valente et al.
SCIENCE (2004)
Roc, a Ras/GTPase domain in complex proteins
L Bosgraaf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2003)
Prospective Belgian study of neurodegenerative and vascular dementia:: APOE genotype effects
S Engelborghs et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
V Bonifati et al.
SCIENCE (2003)
Share Paper
